Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
SoftOx Solutions ASFRA:6FV EV-to-EBITDA is -29.46 as of Aug. 18, 2026. Among 401 Biotechnology companies, SoftOx Solutions AS ranks worse than 249376.31% on this metric.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, SoftOx Solutions AS's enterprise value is €20.54 Mil.
SoftOx Solutions AS's EBITDA for the trailing twelve months (TTM) ended in Dec. 2025 was €-0.70 Mil. Therefore, SoftOx Solutions AS's EV-to-EBITDA for today is -29.46.
The historical rank and industry rank for SoftOx Solutions AS's EV-to-EBITDA or its related term are showing as below:
FRA:6FV'
s EV-to-EBITDA Range Over the Past 10 Years
Min: -36.24 Med: -6.07 Max: -0.19
Current: -27.53
During the past 10 years, the highest EV-to-EBITDA of SoftOx Solutions AS was -0.19. The lowest was -36.24. And the median was -6.07.
FRA:6FV's EV-to-EBITDA is ranked worse than 100% of 401
companies
in the Biotechnology industry
Industry Median: 13.8
vs FRA:6FV: -27.53
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
SoftOx Solutions AS (FRA:6FV) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
SoftOx Solutions AS's PE Ratio (TTM) for today is calculated as:
SoftOx Solutions AS's share price for today is €0.008.
SoftOx Solutions AS's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.000.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
The historical data trend for SoftOx Solutions AS's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:6FV vs VRTX, REGN, RVMD: EV-to-EBITDA Comparison
For the Biotechnology subindustry, SoftOx Solutions AS's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
SoftOx Solutions AS EV-to-EBITDA vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, SoftOx Solutions AS's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where SoftOx Solutions AS's EV-to-EBITDA falls into.
SoftOx Solutions AS's current Enterprise Value is €20.54 Mil.
SoftOx Solutions AS's EBITDA for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was €-0.70 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SoftOx Solutions AS (FRA:6FV) has a EV-to-EBITDA of -29.46 as of Aug. 18, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on SoftOx Solutions AS. According to the industry distribution chart, SoftOx Solutions AS ranks #999999 out of 401 companies in the Biotechnology industry.
Is SoftOx Solutions AS's EV-to-EBITDA too high?
SoftOx Solutions AS's current EV-to-EBITDA is -29.46. Based on the distribution chart, SoftOx Solutions AS ranks #999999 out of 401 companies in the Biotechnology industry, which is in the bottom quartile relative to peers.
How does SoftOx Solutions AS's EV-to-EBITDA compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, SoftOx Solutions AS ranks #999999 out of 401 companies for EV-to-EBITDA. This places SoftOx Solutions AS in the lower half of its industry. The industry median EV-to-EBITDA is 13.80. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Biotechnology company?
The median EV-to-EBITDA among Biotechnology companies is 13.80, based on 401 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on SoftOx Solutions AS. For the Biotechnology industry, the median EV-to-EBITDA is 13.80 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. SoftOx Solutions AS's current EV-to-EBITDA is -29.46. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SoftOx Solutions AS stock overvalued right now?
SoftOx Solutions AS (FRA:6FV) has a current EV-to-EBITDA of -29.46. The current EV-to-EBITDA is -29.46. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For SoftOx Solutions AS (FRA:6FV), the current EV-to-EBITDA is -29.46 as of Aug. 18, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
SoftOx Solutions AS is a clinical-stage pharmaceutical company. It offers antimicrobial solutions for Wound and Skin Care. It has developed an effective antimicrobial solution to combat biofilm, viral, and antimicrobial-resistant infections. The technology is based on extensive research and development in partnership with Nordic research institutes.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:6FV has been successfully added to your 
